Retrospective Review of Outcomes of Conversion Total Hip Arthroplasty Following Failed Internal Fixation at Mean 3.1-Year Follow-Up
Related Experiment Video
Updated: Jul 2, 2026
The Use of Mixed Reality in Custom-Made Revision Hip Arthroplasty: A First Case Report
Published on: August 4, 2022
Adam Bridger1, Daniel Axelrod2, Ravianne Tuazon3
1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
Conversion total hip arthroplasty (THA) after failed hip fracture fixation offers good survivorship and improved function. This study shows acceptable outcomes for THA following open reduction and internal fixation (ORIF) failure.
Area of Science:
- Orthopedic Surgery
- Arthroplasty
- Trauma Surgery
Background:
- Conversion total hip arthroplasty (THA) after failed open reduction and internal fixation (ORIF) of hip fractures is complex.
- Outcomes for conversion THA are less studied than primary or revision THA.
Purpose of the Study:
- To evaluate the three- to five-year survivorship and clinical outcomes of conversion THA following failed ORIF for hip fracture.
Main Methods:
- Retrospective review of 47 patients (42 THA, 5 bipolar hemiarthroplasty) with failed ORIF.
- Kaplan-Meier survivorship analysis with failure defined as revision surgery.
- Mean follow-up was 3.1 years.
Main Results:
- Three- to five-year survivorship was 88.2% for conversion hip arthroplasty.
- Overall complication rate was 21.3%, with infection (10.6%) most common.
- Harris hip scores improved significantly (47.5 to 83.3), and all patients were ambulatory postoperatively.
Conclusions:
- Conversion THA for failed ORIF of hip fractures demonstrates acceptable survivorship and clinical results.
- Further research with larger cohorts and longer follow-up is warranted.
Background:
Conversion total hip arthroplasty (THA) following failed open reduction and internal fixation (ORIF) of a hip fracture is a challenging and complex procedure. While outcomes and surgical considerations of primary and revision THA are well reported in the literature, conversion THA remains far less studied. This study evaluates the three- to five-year survivorship and clinical outcomes of conversion THA following failed ORIF to treat a hip fracture.
Methods:
A total of 47 patients who underwent conversion hip arthroplasty between January 1, 2011, and December 31, 2024, were identified for our retrospective review. Of these, 42 patients underwent conversion THA, and five underwent conversion bipolar hemiarthroplasty. Overall, 31 of 47 (66.0%) were women, the mean age at surgery was 66 years (range, 16 to 101), and the mean follow-up was 3.1 years (range, 0.25 to 16). Kaplan-Meier survivorship analysis was conducted with failure defined as revision surgery for any reason.
Results:
Kaplan-Meier survivorship for patients who underwent conversion hip arthroplasty due to all-cause failure was 88.2% at one, three, and five years (95% confidence interval 98.6 to 78.9) with 29, 14, and six hips at risk, respectively. The overall complication rate was 21.3%, with infection being the most prevalent (10.6%). The overall reoperation rate was 10.6%. Reasons for revision included infection (6.4%), dislocation (2.1%), and abductor insufficiency (2.1%). Harris Hip Scores significantly increased from 47.5 (standard deviation 18.15) preoperatively to 83.3 (standard deviation 9.64) at final postoperative follow-up (P < 0.001). All patients (100.0%) were ambulatory at follow-up. Of these, 59.3% demonstrated normal gait, 18.5% demonstrated antalgic gait, and 22.2% demonstrated Trendelenburg gait postoperatively.
Conclusions:
Conversion THA to treat failed ORIF of a hip fracture provides acceptable three- to five-year survivorship and clinical outcomes. Future studies should investigate larger patient cohorts and patient-reported outcomes across a longer follow-up period.
